Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 4, 2007

View Archived Issues

BioGeneriX and Neose extend GlycoPEG-GCSF collaboration

NovaDel raises funds to advance oral spray drug candidates

Thalidomide to be evaluated for the treatment of MIA syndrome in dialysis patients / News in Context

Grazax launched in U.K., Denmark and Norway

FDA approval for generic Atenolol Tablets

Shandong Luye acquires cancer drug CMNa

Exelixis and Genentech sign agreement for MEK inhibitor XL-518

4SC and XL TechGroup form new company to develop biofilm inhibitors

Grifols receives FDA approval for new generation of IVIG

Zydus launches Simvastatin Tablets

Perrigo receives FDA approval for Ciclopirox Topical Suspension

REG1 anticoagulant system safe in humans

VGX-1027 active against diabetes in preclinical models

PRO-132365 investigated in breast cancer trial

E75 vaccine safe and active in high-risk breast cancer

Novel monoamine reuptake inhibitors emerge from NeuroSearch R&D

Novel antibacterial agents patented

New CCR-5 receptor modulators prepared and tested at Kemia

Higher recovery rate after stroke for DP-b99-treated patients

Transdur-Bupivacaine begins phase II for postherpetic neuralgia

Phase II program under way for TD-1792 in Gram-positive cSSSI

SPA agreement for pivotal phase III study of picoplatin in SCLC

U.K. clearance for clinical study of Reolysin with docetaxel in advanced cancers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...